Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20020 (
adenosine triphosphatase
)
3,299
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fertilized hen eggs were treated externally with 2,4-dichlorophenoxyacetic butyl ester (
2,4-D
b.e.) (3.1 mg/egg) before the start of the incubation. Actomyosin and sarcoplasmic reticulum
adenosine triphosphatase
(
ATPase
) activities from leg and complexus muscles of chicks hatched from treated eggs were measured. No significant variations were detected in the
ATPase
activities of actomyosin, but the sarcoplasmic reticulum Mg2(+)-activated
ATPase
and Ca2+, Mg2(+)-activated
ATPase
were inhibited 50 and 38% respectively. 45Ca2+ uptake into soleus muscle was increased by the
2,4-D
b.e. treatment. The compartmental analysis of 45Ca2+ uptake kinetics showed increases in Ca2+ fluxes in sarcolemma and mitochondria and in the mitochondrial calcium pool. Isolated soleus muscles were treated with 2,4-dichlorophenoxyacetic acid (
2,4-D
) or
2,4-D
b.e. [14C]
2,4-D
reached it highest level in these muscles after 1 hr of treatment. The in vitro treatment with
2,4-D
or
2,4-D
b.e. increased 45Ca2+ uptake into the muscles.
2,4-D
b.e. produced greater alterations than
2,4-D
. The compartmental analysis of the 45Ca2+ uptake kinetics also showed increases of the mitochondrial Ca2+ pool and Ca2+ fluxes through sarcolemma and mitochondria. These results led to a hypothesis based on Ca2+ permeability alterations for explaining the myopathic actions of these phenoxyherbicides.
...
PMID:Ca2+ homeostasis alterations induced by 2,4-dichlorophenoxyacetic butyl ester and 2,4-dichlorophenoxyacetic acid on avian skeletal muscle. 214 78